VUMC News and Communications
-
December 13, 2012
CDC selects VU to lead national adverse vaccine event reviews
Vanderbilt University Medical Center has been selected by the Centers for Disease Control and Prevention (CDC), to lead a consortium of top national experts in vaccine safety in performing timely reviews of adverse vaccine events. -
December 13, 2012
New Neurology residency program director brings global perspective
After a decade of growth in the Department of Neurology’s residency program, Heather Koons, M.D., is stepping into the role of program director and brings a uniquely international perspective. -
December 10, 2012
Genetic clues to lung scarring
A rare genetic syndrome provides new clues to lung scarring (pulmonary fibrosis), a potentially deadly consequence of many lung diseases. -
December 7, 2012
Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators. -
December 7, 2012
Breast milk blocks virus binding
Components of human breast milk help ward off viral infection, a new study shows. -
December 6, 2012
Vice Chancellor Balser: ‘Cliff’ looming for biomedical research
"Beyond the damaging effects on the health of our people, disrupting the nation’s biomedical science infrastructure puts our economic future at risk," writes Vice Chancellor for Health Affairs Jeff Balser in The Tennessean.